Sage Journals: Discover world-class research

Abstract

Background:

Observational studies have found an association between attention-deficit/hyperactivity disorder (ADHD) and ischemic stroke.

Aims:

The purpose of this study was to investigate whether genetic liability to ADHD has a causal effect on ischemic stroke and its subtypes.

Methods:

In this two-sample Mendelian randomization (MR) study, genetic variants (nine single-nucleotide polymorphisms; P < 5 × 10^-8) using as instrumental variables for the analysis was obtained from a genome-wide association study of ADHD with 19,099 cases and 34,194 controls. The outcome datasets for stroke and its subtypes were obtained from the MEGASTROKE consortium, with 40,585 cases and 406,111 controls. MR inverse variance-weighted method was conducted to investigate the effect of genetic liability to ADHD on ischemic stroke and its subtypes. Sensitivity analyses (median-based methods, MR-Egger, MR-robust adjusted profile scores, MR-pleiotropy residual sum and outlier) were also utilized to assess horizontal pleiotropy and remove outliers. Multivariable MR (MVMR) analyses were conducted to explore potential mediators.

Results:

Genetically determined ADHD (per 1 SD) was significantly associated with a higher risk of any ischemic stroke (AIS) (odds ratio (OR) = 1.15, 95% confidence interval (CI) = 1.05–1.25, P = 0.002) and large-artery atherosclerotic stroke (LAS) (OR = 1.40, 95% CI = 1.10–1.76, P = 0.005). The significant association was also found in sensitivity analyses and MVMR analyses.

Conclusions:

Genetic liability to ADHD was significantly associated with an increased risk of AIS, especially LAS. The association between ADHD and LAS was independent of age of smoking initiation but mediated by coronary artery disease.

Keywords

Attention-deficit/hyperactivity disorder ischemic stroke Mendelian randomization

Get full access to this article

View all access options for this article.

References

GBD. 2019 stroke collaboratorsglobal, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 2021; 20: 795–820.

Zhou

Wang

Zeng

, et al Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2019; 394: 1145–1158.

Adams

Jr Bendixen

Kappelle

, et al Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 1993; 24: 35–41.

Sayal

Prasad

Daley

Ford

Coghill

. ADHD in children and young people: prevalence, care pathways, and service provision. Lancet Psychiatry 2018; 5: 175–186.

Shaw

Hodgkins

Caci

, et al A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med 2012; 10: 99.

Chen

Hartman

Kuja-Halkola

Faraone

Almqvist

Larsson

. Attention-deficit/hyperactivity disorder and clinically diagnosed obesity in adolescence and young adulthood: a register-based study in Sweden. Psychol Med 2019; 49: 1841–1849.

Fuemmeler

Østbye

Yang

McClernon

Kollins

. Association between attention-deficit/hyperactivity disorder symptoms and obesity and hypertension in early adulthood: a population-based study. Int J Obes (Lond) 2011; 35: 852–862.

Cortese

Sun

Zhang

, et al Association between attention deficit hyperactivity disorder and asthma: a systematic review and meta-analysis and a Swedish population-based study. Lancet Psychiatry 2018; 5: 717–726.

Leppert

Riglin

Wootton

, et al The effect of attention deficit/hyperactivity disorder on physical health outcomes: a 2-sample Mendelian randomization study. Am J Epidemiol 2021; 190: 1047–1055.

10.

Ferreira

MGR

Moro

CHC

Franco

. Cognitive performance after ischaemic stroke. Dement Neuropsychol 2015; 9: 165–175.

11.

Williams

Roberts

Coppens

, et al Secondary attention-deficit/hyperactivity disorder following perinatal and childhood stroke: impact on cognitive and academic outcomes. Child Neuropsychol 2017; 24: 1–21.

12.

O’Keeffe

Liégeois

Eve

, et al Neuropsychological and neurobehavioral outcome following childhood arterial ischemic stroke: attention deficits, emotional dysregulation, and executive dysfunction. Child Neuropsychol 2014; 20: 557–582.

13.

Davies

Holmes

Davey Smith

. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 2018; 362: k601.

14.

Sanderson

Davey Smith

Windmeijer

, et al An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings. Int J Epidemiol 2019; 48: 713–727.

15.

Demontis

Walters

Martin

, et al Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat Genet 2019; 51: 63–75.

16.

Malik

Chauhan

Traylor

, et al Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nature Genetics 2018; 50: 524–537.

17.

Arnold

Raffler

Pfeufer

, et al SNiPA: an interactive, genetic variant-centered annotation browser. Bioinformatics 2014; 31: 1334–1336.

18.

Pierce

Burgess

. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol 2013; 178: 1177–1184.

19.

Burgess

Butterworth

Thompson

. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 2013; 37: 658–665.

20.

Burgess

Thompson

Rees

JMB

Day

Perry

Ong

. Dissecting causal pathways using Mendelian randomization with summarized genetic data: application to age at menarche and risk of breast cancer. Genetics 2017; 207: 481–487.

21.

Bowden

Davey Smith

Haycock

Burgess

. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 2016; 40: 304–314.

22.

Zhao

Wang

Hemani

, et al Statistical inference in two-sample summary-data Mendelian randomization using robust adjusted profile score, 2018, https://ui.adsabs.harvard.edu/abs/2018arXiv180109652Z (accessed 1 January 2018).

23.

Bowden

Davey Smith

Burgess

. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 2015; 44: 512–525.

24.

Greco

Minelli

Sheehan

Thompson

. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med 2015; 34: 2926–2940.

25.

Bowden

Del Greco

Minelli

, et al A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med 2017; 36: 1783–1802.

26.

Verbanck

Chen

Neale

, et al Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 2018; 50: 693–698.

27.

Hemani

Tilling

Davey Smith

. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet 2017; 13: e1007081.

28.

Stroke: challenges, progress, and promise. Bethesda, MD: National Institute of Neurological Disorders and Stroke, 2009.

29.

Centers for Disease Control Prevention (US). Conditions that increase risk for stroke, 2020, https://www.cdc.gov/stroke/conditions.htm (accessed 8 December 2021).

30.

Kollins

McClernon

Fuemmeler

. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch Gen Psychiatry 2005; 62: 1142–1147.

31.

Larsson

Mason

Bäck

, et al Genetic predisposition to smoking in relation to 14 cardiovascular diseases. Europ Heart J 2020; 41: 3304–3310.

32.

Larsson

Burgess

Michaëlsson

. Smoking and stroke: a Mendelian randomization study. Ann Neurol 2019; 86: 468–471.

33.

Nikpay

Goel

Won

, et al A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet 2015; 47: 1121–1130.

34.

Liu

Jiang

Wedow

, et al Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat Genet 2019; 51: 237–244.

35.

Sanderson

Spiller

Bowden

. Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization. Stat Med 2021; 40: 5434–5452.

36.

Lee

Humphreys

Flory

, et al Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev 2011; 31: 328–341.

37.

Milberger

Biederman

Faraone

, et al ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry 1997; 36: 37–44.

38.

Qian

, et al Role of cigarette smoking in the development of ischemic stroke and its subtypes: a Mendelian randomization study. Clin Epidemiol 2019; 11: 725–731.

39.

Campos

Serebrisky

Castaldelli-Maia

. Smoking and cognition. Current Drug Abuse Reviews 2016; 9: 76–79.

40.

Taylor

Lindson

Farley

, et al Smoking cessation for improving mental health. Cochrane Database Syst Rev 2021; 3: CD013522.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.63 MB

Attention-deficit/hyperactivity disorder and ischemic stroke: A Mendelian randomization study

Abstract

Background:

Aims:

Methods:

Results:

Conclusions:

Keywords

Get full access to this article

References

Supplementary Material